标题
Biological and clinical heterogeneity of MYCN-amplified medulloblastoma
作者
关键词
-
出版物
ACTA NEUROPATHOLOGICA
Volume 123, Issue 4, Pages 515-527
出版商
Springer Nature
发表日期
2011-12-08
DOI
10.1007/s00401-011-0918-8
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups
- (2011) David W. Ellison et al. ACTA NEUROPATHOLOGICA
- Adult Medulloblastoma Comprises Three Major Molecular Variants
- (2011) Marc Remke et al. JOURNAL OF CLINICAL ONCOLOGY
- FSTL5Is a Marker of Poor Prognosis in Non-WNT/Non-SHH Medulloblastoma
- (2011) Marc Remke et al. JOURNAL OF CLINICAL ONCOLOGY
- Molecular diagnostics of CNS embryonal tumors
- (2010) Stefan M. Pfister et al. ACTA NEUROPATHOLOGICA
- Childhood medulloblastoma: novel approaches to the classification of a heterogeneous disease
- (2010) David W. Ellison ACTA NEUROPATHOLOGICA
- Pleiotropic role for MYCN in medulloblastoma
- (2010) F. J. Swartling et al. GENES & DEVELOPMENT
- Arsenic trioxide inhibits human cancer cell growth and tumor development in mice by blocking Hedgehog/GLI pathway
- (2010) Elspeth M. Beauchamp et al. JOURNAL OF CLINICAL INVESTIGATION
- Clinical Experience With Hedgehog Pathway Inhibitors
- (2010) Jennifer A. Low et al. JOURNAL OF CLINICAL ONCOLOGY
- Adult and Pediatric Medulloblastomas Are Genetically Distinct and Require Different Algorithms for Molecular Risk Stratification
- (2010) Andrey Korshunov et al. JOURNAL OF CLINICAL ONCOLOGY
- TP53 Mutation Is Frequently Associated With CTNNB1 Mutation or MYCN Amplification and Is Compatible With Long-Term Survival in Medulloblastoma
- (2010) Elke Pfaff et al. JOURNAL OF CLINICAL ONCOLOGY
- Integrative Genomic Analysis of Medulloblastoma Identifies a Molecular Subgroup That Drives Poor Clinical Outcome
- (2010) Yoon-Jae Cho et al. JOURNAL OF CLINICAL ONCOLOGY
- Definition of Disease-Risk Stratification Groups in Childhood Medulloblastoma Using Combined Clinical, Pathologic, and Molecular Variables
- (2010) David W. Ellison et al. JOURNAL OF CLINICAL ONCOLOGY
- Medulloblastoma Comprises Four Distinct Molecular Variants
- (2010) Paul A. Northcott et al. JOURNAL OF CLINICAL ONCOLOGY
- Low-level copy number changes of MYC genes have a prognostic impact in medulloblastoma
- (2010) Karel Zitterbart et al. JOURNAL OF NEURO-ONCOLOGY
- Genomics of medulloblastoma: from Giemsa-banding to next-generation sequencing in 20 years
- (2010) Paul A. Northcott et al. Neurosurgical Focus
- Non-negative matrix factorization of gene expression profiles: a plug-in for BRB-ArrayTools
- (2009) Q. Qi et al. BIOINFORMATICS
- The miR-17/92 Polycistron Is Up-regulated in Sonic Hedgehog-Driven Medulloblastomas and Induced by N-myc in Sonic Hedgehog-Treated Cerebellar Neural Precursors
- (2009) P. A. Northcott et al. CANCER RESEARCH
- Hedgehog Target Genes: Mechanisms of Carcinogenesis Induced by Aberrant Hedgehog Signaling Activation
- (2009) Y. Katoh et al. CURRENT MOLECULAR MEDICINE
- N-myc alters the fate of preneoplastic cells in a mouse model of medulloblastoma
- (2009) J. D. Kessler et al. GENES & DEVELOPMENT
- Outcome Prediction in Pediatric Medulloblastoma Based on DNA Copy-Number Aberrations of Chromosomes 6q and 17q and theMYCandMYCNLoci
- (2009) Stefan Pfister et al. JOURNAL OF CLINICAL ONCOLOGY
- Accumulation of genomic aberrations during clinical progression of medulloblastoma
- (2008) Andrey Korshunov et al. ACTA NEUROPATHOLOGICA
- Integrated Genomics Identifies Five Medulloblastoma Subtypes with Distinct Genetic Profiles, Pathway Signatures and Clinicopathological Features
- (2008) Marcel Kool et al. PLoS One
- Distinct transcriptional MYCN/c-MYC activities are associated with spontaneous regression or malignant progression in neuroblastomas
- (2008) Frank Westermann et al. GENOME BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started